Eden Research
EDEN · AIM · Chemicals · mcap £19m · 2.3p
| Date | Type | Announcement | Day |
|---|---|---|---|
| 06 Oct 26 | Investor presentation
Eden BioSolutions plc (AIM: EDEN), a leader in sustainable biopesticide and biocontrol technology, will provide an update to shareholders on the IMC platform, delivering the same presentation that was used at the Company |
+0.0% | |
| 01 Oct 26 | Routine | Change of Name | |
| 29 Sep 26 | Routine | Result of AGM | |
| 29 Sep 26 | AGM Statement
Eden Research plc (AIM: EDEN), a leader in sustainable biopesticide and biocontrol technology, provides an update to shareholders ahead of its Annual General Meeting (‘AGM’) today at Cavendish's office, 1 Bartholomew Clo |
+0.0% | |
| 28 Sep 26 | US EPA approves expanded label for Mevalone
Eden Research plc (AIM: EDEN), the AIM-quoted company focused on sustainable biopesticides and plastic-free formulation technology for global agriculture, announces that the United States Environmental Protection Agency |
+4.8% | |
| 17 Sep 26 | Director dealing | Grant of Awards under LTIP PDMR Dealing | |
| 07 Sep 26 | Routine | Notice of AGM | |
| 26 Aug 26 | Results | Final Results
Preliminary results for the 15 months ended 31 March 2026 |
−6.4% |
| 25 Aug 26 | Routine | Notice of Results | |
| 04 Aug 26 | Regulatory approvals in Slovakia and Egypt
Eden extends its European footprint and secures its first authorisation for Mevalone® in North Africa |
+0.0% | |
| 25 Jun 26 | 2026 Green Economy Mark
Eden Research plc (AIM: EDEN), a leader in sustainable biopesticide and biocontrol technology, confirms that the Company has been included in the London Stock Exchange's 2026 Green Economy Mark cohort, comprising of 95 c |
+0.0% | |
| 27 May 26 | Board change | Directorate Change
Eden Research plc (AIM: EDEN), a leader in sustainable biopesticide and biocontrol technology, announces that Derek McAllan has stepped down from the Board with immediate effect due to ill health. |
+0.0% |
| 28 Apr 26 | Trading update | Trading Update
Eden Research plc (AIM: EDEN), a leader in sustainable biopesticide and biocontrol technology, provides the following unaudited trading update. |
−8.3% |
| 16 Apr 26 | Holding | Holding(s) in Company | |
| 14 Apr 26 | Holding | Holding(s) in Company | |
| 14 Apr 26 | Holding | Holding(s) in Company | |
| 13 Apr 26 | Holding | Holding(s) in Company | |
| 10 Apr 26 | Fundraise | Completion of Conditional Placing and TVR
The Board of Eden Research plc (the "Company") (AIM: EDEN), a leader in sustainable biopesticide and biocontrol technologies, is pleased to announce the successful completion of its Conditional Placing, as previously ann |
+18.2% |
| 08 Apr 26 | Fundraise | Satisfaction of Conditions of Conditional Placing
Further to the Company's announcement on 2 February 2026, the Board of Eden Research plc (the "Company") (AIM: EDEN), a leader in sustainable biopesticide and biocontrol technologies, is pleased to confirm that all condi |
−3.5% |
| 02 Apr 26 | Thymolflex EPA approval
Eden Research plc (AIM: EDEN), a leader in sustainable biopesticide and biocontrol technologies, is pleased to announce that the Company's partner, Véto-pharma, has received regulatory approval from the US Environmental |
−1.7% | |
| 19 Feb 26 | Holding | Holding(s) in Company | |
| 19 Feb 26 | Holding | Holding(s) in Company | |
| 18 Feb 26 | Routine | Result of General Meeting and Total Voting Rights | |
| 05 Feb 26 | Fundraise | Result of Retail Offer
The Board of Eden Research plc (the "Company") (AIM: EDEN), a leader in sustainable biopesticide and biocontrol technologies, is pleased to announce that the Retail Offer launched on 2 February 2026 has now closed, raisi |
−3.7% |
| 02 Feb 26 | Fundraise | Launch of Retail Offer
The Board of Eden Research plc (the "Company") is pleased to announce a retail offer via BookBuild (the "Retail Offer") of new ordinary shares ("Ordinary Shares") of £0.01 each in the capital of the Company (the "Retail |
+1.3% |
| 02 Feb 26 | Fundraise | Proposed Placing and Subscription
THIS ANNOUNCEMENT SHOULD BE READ IN ITS ENTIRETY. |
+1.3% |
| 09 Jan 26 | Novellus+ Regulatory Authorisation in Chile
Eden receives its first authorisation in South America, in one of the world's largest wine-exporting markets |
+18.0% | |
| 07 Jan 26 | Mevalone Label Extension in France
Mevalone® approved in France for use on grapes against downy and powdery mildew |
+14.8% | |
| 18 Dec 25 | Appointment of Syngenta as Distribution Partner
Eden Research plc (AIM: EDEN), a leader in sustainable biopesticide and biocontrol technology, is pleased to announce the appointment of Syngenta Crop Protection AG ("Syngenta") as the Company's exclusive distribution pa |
+8.3% | |
| 20 Nov 25 | 3LOGY Label Extension in Italy
3LOGY® has been approved in Italy for use across an additional range of new crops and a number of new disease targets. |
+2.3% | |
| 17 Nov 25 | Ecovelex 2025 Approval in Italy
Ecovelex has been granted temporary authorisation in Italy, providing farmers with continued access to sustainable maize seed treatments to repel birds for the 2026 growing season |
+0.0% |
Company filings. Not investment advice.